Independent forensic audit appointed for FY2022-23 through FY2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 3.9 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ASGM and Co. will review Vaxfab's records and transactions for FY2022-23 through FY2024-25. The review follows incomplete record handover after management changed on April 1, 2025, and GST queries about historical input tax credit. Fees are Rs 3 lakh plus taxes and approved costs. Scope includes accounts, GST, tax matters and related-party transactions. It is not a statutory audit and no wrongdoing is presumed. Findings will go to the Board, which may prompt corrective or regulatory action.
The stock may face uncertainty over historical accounts and tax or regulatory exposure; no wrongdoing or financial impact is established.